Cargando…
Biased agonism
Seven-transmembrane receptors are commonly coupled to multiple signaling pathways in cells. The simple model describing agonists for these receptors as producing a common active state to induce uniform activation of the pathways linked to the receptor has been shown to be untenable in light of a lar...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biology Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948287/ https://www.ncbi.nlm.nih.gov/pubmed/20948603 http://dx.doi.org/10.3410/B1-87 |
_version_ | 1782187438334017536 |
---|---|
author | Kenakin, Terry |
author_facet | Kenakin, Terry |
author_sort | Kenakin, Terry |
collection | PubMed |
description | Seven-transmembrane receptors are commonly coupled to multiple signaling pathways in cells. The simple model describing agonists for these receptors as producing a common active state to induce uniform activation of the pathways linked to the receptor has been shown to be untenable in light of a large body of data that suggest that some agonists produce activation of some but not all available pathways. These agonists are referred to as ‘biased’ in that they select which signaling pathways become activated upon binding to the receptor. The data to support this mechanism as well as ideas on the possible therapeutic application of this effect will be discussed. |
format | Text |
id | pubmed-2948287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Biology Reports Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-29482872010-10-14 Biased agonism Kenakin, Terry F1000 Biol Rep Review Article Seven-transmembrane receptors are commonly coupled to multiple signaling pathways in cells. The simple model describing agonists for these receptors as producing a common active state to induce uniform activation of the pathways linked to the receptor has been shown to be untenable in light of a large body of data that suggest that some agonists produce activation of some but not all available pathways. These agonists are referred to as ‘biased’ in that they select which signaling pathways become activated upon binding to the receptor. The data to support this mechanism as well as ideas on the possible therapeutic application of this effect will be discussed. Biology Reports Ltd 2009-11-26 /pmc/articles/PMC2948287/ /pubmed/20948603 http://dx.doi.org/10.3410/B1-87 Text en © 2009 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Kenakin, Terry Biased agonism |
title | Biased agonism |
title_full | Biased agonism |
title_fullStr | Biased agonism |
title_full_unstemmed | Biased agonism |
title_short | Biased agonism |
title_sort | biased agonism |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948287/ https://www.ncbi.nlm.nih.gov/pubmed/20948603 http://dx.doi.org/10.3410/B1-87 |
work_keys_str_mv | AT kenakinterry biasedagonism |